SCHEMBL25662323

SCHEMBL25662323

N[C@H](COC1CCOCC1)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.35
▸ WDR77 Q9BQA1 1/20 0.35
▸ PTGS1 P23219 1/20 0.33
▸ SLC7A11 Q9UPY5 1/20 0.33
▸ GRIK1 P39086 3/20 0.33
▸ GRIK2 Q13002 2/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ SPHK1 Q9NYA1 1/20 0.32
▸ SLC1A3 P43003 3/20 0.32
▸ SLC1A2 P43004 3/20 0.32
▸ SLC1A1 P43005 3/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ SLC7A5 Q01650 1/20 0.31
▸ GRM8 O00222 1/20 0.31
▸ GRM6 O15303 1/20 0.31
▸ GRIN2D O15399 1/20 0.31
▸ GRIN3B O60391 1/20 0.31
▸ GSR P00390 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25660601 1.00 PRMT5 (0.35) PRMT5WDR77PTGS1SLC7A11GRIK1
SCHEMBL29855094 0.87 PTGS1 (0.39) PTGS1SLC7A11GRIK1GRIK2NOS3
SCHEMBL29855065 0.83 SLC1A3 (0.40) PTGS1SLC7A11GRIK1GRIK2NOS3
SCHEMBL25662192 0.83 SLC1A3 (0.40) PTGS1SLC7A11GRIK1GRIK2NOS3
SCHEMBL25356880 0.83 GRIK1 (0.42) PTGS1SLC7A11GRIK1GRIK2NOS3
SCHEMBL25356877 0.83 GRIK1 (0.42) PTGS1SLC7A11GRIK1GRIK2NOS3
SCHEMBL25660424 0.83 SLC1A3 (0.40) PTGS1SLC7A11GRIK1GRIK2NOS3
SCHEMBL25355147 0.83 GSR (0.37) GRIK1GRIK2NOS3NOS1NOS2
SCHEMBL25355141 0.83 GSR (0.37) GRIK1GRIK2NOS3NOS1NOS2
SCHEMBL3447889 0.81 GRIK1 (0.44) PTGS1SLC7A11GRIK1GRIK2SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158179-A1 RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF RAYZEBIO, INC. 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158179-A1 RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF PAICS, LNPEP, DNPEP PRMT5 140/4885WDR77 1881/4885PTGS1 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback